clinical trials glp-1 Market Overview: Agonists and the Obesity Market | Blog Clinical research solutions for GLP-1

At our platform, we understand that weight loss is not a one-size-fits-all process

High costs serve as barrier to care High out-of-pocket costs for people without insurance coverage remain a key factor in determining who can benefit from GLP-1 medications and who cannot, said Tracy Svenyach, PhD, director of policy strategy and alliance at the Obesity Action Coalition

Then introduce Pendulum once the gut ecosystem has regained some stability

We can show you how to burn fat without all of the traditional, stifling silliness of counting calories and flipping your world upside down to fit into the clothes you want

Nature 597 , 709714 (2021)